CONVERSION THERAPY

Clinical trials for CONVERSION THERAPY explained in plain language.

Never miss a new study

Get alerted when new CONVERSION THERAPY trials appear

Sign up with your email to follow new studies for CONVERSION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New test aims to perfect timing for liver cancer surgery

Disease control Not yet recruiting

This study is for people with a type of advanced liver cancer called intrahepatic cholangiocarcinoma. It tests whether a new evaluation system (TDTP-RECIST) can better guide doctors on when to perform surgery after patients have received initial drug therapy (GOLP regimen). The g…

Matched conditions: CONVERSION THERAPY

Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Apr 02, 2026 02:26 UTC

CONVERSION THERAPY

Get alerted when new CONVERSION THERAPY trials appear

New test aims to perfect timing for liver cancer surgery